Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

LongBio Pharma is a biotech company based in Shanghai, China, established in 2018. The company has a focus on autoimmune and rare diseases with a commitment to serving patients and society. Dr. Sun, Bill, Nai-chau, co-founder of LongBio Pharma, has a notable background as the co-founder of Tanox, which went public on Nasdaq in 2000 and was later acquired by Genentech in 2007. He is also the co-inventor of Omalizumab (Xolair®)...
LongBio Pharma is a biotech company based in Shanghai, China, established in 2018. The company has a focus on autoimmune and rare diseases with a commitment to serving patients and society. Dr. Sun, Bill, Nai-chau, co-founder of LongBio Pharma, has a notable background as the co-founder of Tanox, which went public on Nasdaq in 2000 and was later acquired by Genentech in 2007. He is also the co-inventor of Omalizumab (Xolair®), the first anti-IgE antibody approved by the FDA, with global sales reaching 3.6 billion USD in 2022. LongBio Pharma aims to introduce its drugs to both domestic and international markets through partnerships.

List your booth number for exhibitions, ask us